Apyx Medical (APYX) Shares Outstanding (Weighted Average) (2010 - 2026)

Apyx Medical (APYX) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $43.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 7.4% year-over-year to $43.7 million; the trailing twelve-month figure through Mar 2026 stood at $43.7 million (up 7.4% YoY), and the FY2025 full-year result was $41.1 million, up 15.62% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $43.7 million, up from $41.1 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $43.7 million in Q1 2026 and bottomed at $34.4 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $34.6 million (2024), against an average of $36.6 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) grew 0.01%; it then rose 17.62% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $34.5 million in 2022, then grew by 0.31% to $34.6 million in 2023, then rose by 2.66% to $35.5 million in 2024, then advanced by 15.62% to $41.1 million in 2025, then increased by 6.44% to $43.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $43.7 million (Q1 2026), $41.1 million (Q4 2025), and $40.7 million (Q3 2025), per Business Quant data.

Peer Comparison